Low-Dose-Rate Brachytherapy as Monotherapy for High-Risk Prostate Cancer: 15-Year Outcomes Data

被引:0
|
作者
Lazarev, Stanislav [1 ]
Liu, Jerry [1 ]
Thompson, Marcher [1 ]
Ghiassi, Zahra [1 ]
Stone, Nelson N. [1 ]
Stock, Richard G. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
D O I
10.1016/j.ijrobp.2018.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA19
引用
收藏
页码:E8 / E9
页数:2
相关论文
共 50 条
  • [1] Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan
    Tanaka, Nobumichi
    Asakawa, Isao
    Hasegawa, Masatoshi
    Fujimoto, Kiyohide
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (01) : 17 - 23
  • [2] Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
    Barnes, Justin
    Kennedy, William R.
    Fischer-Valuck, Benjamin W.
    Baumann, Brian C.
    Michalski, Jeff M.
    Gay, Hiram A.
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2019, 11 (04) : 320 - 328
  • [3] Five-Year Treatment Outcome of High-Risk Prostate Cancer Following Radical Prostatectomy, Low-dose-rate, or High-dose-rate Brachytherapy
    Yoshiyama, Y.
    Kido, M.
    Yamamoto, T.
    Kimura, T.
    Miki, K.
    Aoki, M.
    Egawa, S.
    [J]. UROLOGY, 2012, 80 (03) : S346 - S346
  • [4] High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
    Behmueller, Manuel
    Tselis, Nikolaos
    Zamboglou, Nikolaos
    Zoga, Eleni
    Baltas, Dimos
    Roedel, Claus
    Chatzikonstantinou, Georgios
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy - Counterpoint
    Stock, Richard G.
    [J]. BRACHYTHERAPY, 2006, 5 (01) : 5 - 6
  • [6] Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
    Okamoto, Keisei
    Okuyama, Kahori
    Kohno, Naoaki
    Tsugawa, Takuya
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (01) : 6 - 11
  • [7] Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
    Agarwal, Manuj
    Chhabra, Arpit M.
    Amin, Neha
    Braccioforte, Michelle H.
    Molitoris, Jason K.
    Moran, Brian J.
    [J]. BRACHYTHERAPY, 2018, 17 (06) : 882 - 887
  • [8] The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer
    Shaikh, Talha
    Wang, Lora
    Ruth, Karen
    Hallman, Mark
    Chen, David Y.
    Greenberg, Richard E.
    Li, Jinsheng
    Crawford, Kevin
    Horwitz, Eric M.
    [J]. BRACHYTHERAPY, 2016, 15 (02) : 156 - 162
  • [9] Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer
    Kittel, Jeffrey A.
    Reddy, Chandana A.
    Smith, Kristin L.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    Ulchaker, James
    Angermeier, Kenneth
    Campbell, Steven
    Stephenson, Andrew
    Klein, Eric A.
    Wilkinson, D. Allan
    Ciezki, Jay P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (04): : 884 - 893
  • [10] The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
    Tanaka, Nobumichi
    [J]. PROSTATE INTERNATIONAL, 2023, 11 (03) : 127 - 133